The DOI matches its Crossref record; 97 of the 97 references it cites were found in a registry or an index.
Metabolomics: A Global Biochemical Approach to the Study of Central Nervous System Diseases
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
MACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
Rosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H.-X., et al. (1993) · Nature · doi:10.1038/362059a0 · Cited by 7,062
Mitochondrial Dysfunction and Oxidative Stress in Neurodegenerative Diseases
Lin, M. T., & Beal, M. F. (2006) · Nature · doi:10.1038/nature05292 · Cited by 6,455
Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia
Lieberman, J. A., Stroup, T. S., McEvoy, J. P., Swartz, M. S., Rosenheck, R. A., Perkins, D. O., Keefe, R. S. E., Davis, S. M., Davis, C. E., Lebowitz, B. D., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051688 · Cited by 5,892
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227
Strittmatter, W. J., Saunders, A. M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G. S., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1977 · Cited by 4,268
Psychopharmacology: The Third Generation of Progress.
(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-509_2 · Cited by 2,014
Rowland, L. P., & Shneider, N. A. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105313442207 · Cited by 1,812
Strittmatter, W. J., Weisgraber, K. H., Huang, D. Y., Dong, L. M., Salvesen, G. S., Pericak-Vance, M., Schmechel, D., Saunders, A. M., Goldgaber, D., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.17.8098 · Cited by 1,363
Brindle, J. T., Antti, H., Holmes, E., Tranter, G., Nicholson, J. K., Bethell, H. W. L., Clarke, S., Schofield, P. M., McKilligin, E., Mosedale, D. E., et al. (2002) · Nature Medicine · doi:10.1038/nm1202-802 · Cited by 1,029
Hasler, G., van der Veen, J. W., Tumonis, T., Meyers, N., Shen, J., & Drevets, W. C. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.2.193 · Cited by 846
Thomas, B., & Beal, M. F. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm159 · Cited by 748
Metabolomics: A Global Biochemical Approach to Drug Response and Disease
Kaddurah-Daouk, R., Kristal, B. S., & Weinshilboum, R. M. (2008) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.48.113006.094715 · Cited by 670
Self-citationHan, X., M. Holtzman, D., W. McKeel, D., Kelley, J., & Morris, J. C. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00997.x · Cited by 626
GABAergic dysfunction in mood disorders
Brambilla, P., Perez, J., Barale, F., Schettini, G., & Soares, J. C. (2003) · Molecular Psychiatry · doi:10.1038/sj.mp.4001362 · Cited by 553
Metabolomics and systems biology: making sense of the soup
KELL, D. (2004) · Current Opinion in Microbiology · doi:10.1016/j.mib.2004.04.012 · Cited by 529
Metabolomic Identification of Novel Biomarkers of Myocardial Ischemia
Sabatine, M. S., Liu, E., Morrow, D. A., Heller, E., McCarroll, R., Wiegand, R., Berriz, G. F., Roth, F. P., & Gerszten, R. E. (2005) · Circulation · doi:10.1161/circulationaha.105.569137 · Cited by 461
Metabonomics: Metabolic processes studied by NMR spectroscopy of biofluids
Lindon, J. C., Nicholson, J. K., Holmes, E., & Everett, J. R. (2000) · Concepts in Magnetic Resonance · doi:10.1002/1099-0534(2000)12:5<289::aid-cmr3>3.0.co;2-w · Cited by 460
Horrobin, D. F. (1998) · Schizophrenia Research · doi:10.1016/s0920-9964(97)00151-5 · Cited by 455
Watson, A. D. (2006) · Journal of Lipid Research · doi:10.1194/jlr.r600022-jlr200 · Cited by 455
Wichers, M. C., Koek, G. H., Robaeys, G., Verkerk, R., Scharpé, S., & Maes, M. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001600 · Cited by 445
Machine Learning for Detection and Diagnosis of Disease
Sajda, P. (2006) · Annual Review of Biomedical Engineering · doi:10.1146/annurev.bioeng.8.061505.095802 · Cited by 409
Metabolomic profiling to develop blood biomarkers for Parkinson's disease
Bogdanov, M., Matson, W. R., Wang, L., Matson, T., Saunders-Pullman, R., Bressman, S. S., & Beal, M. F. (2008) · Brain · doi:10.1093/brain/awm304 · Cited by 401
Metabolic Profiling: Its Role in Biomarker Discovery and Gene Function Analysis
(2003) · Springer eBooks · doi:10.1007/978-1-4615-0333-0 · Cited by 390
Lindon, J. C., Nicholson, J. K., Holmes, E., Antti, H., Bollard, M. E., Keun, H., Beckonert, O., Ebbels, T. M., Reily, M. D., Robertson, D., et al. (2003) · Toxicology and Applied Pharmacology · doi:10.1016/s0041-008x(02)00079-0 · Cited by 385
Detection of epithelial ovarian cancer using 1H‐NMR‐based metabonomics
Odunsi, K., Wollman, R. M., Ambrosone, C. B., Hutson, A., McCann, S. E., Tammela, J., Geisler, J. P., Miller, G., Sellers, T., Cliby, W., et al. (2005) · International Journal of Cancer · doi:10.1002/ijc.20651 · Cited by 317
(2010) · The Tomb of Tut-Ankh-Amen · doi:10.1017/cbo9780511722349.008 · Cited by 313
Serum uric acid levels and the risk of Parkinson disease
de Lau, L. M. L., Koudstaal, P. J., Hofman, A., & Breteler, M. M. B. (2005) · Annals of Neurology · doi:10.1002/ana.20663 · Cited by 301
Beyond Monoamines: Glutamatergic Function in Mood Disorders
Kugaya, A., & Sanacora, G. (2005) · CNS Spectrums · doi:10.1017/s1092852900010403 · Cited by 290
Holmes, E., Tsang, T. M., Huang, J. T.-J., Leweke, F. M., Koethe, D., Gerth, C. W., Nolden, B. M., Gross, S., Schreiber, D., Nicholson, J. K., et al. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030327 · Cited by 290
Wang, C., Kong, H., Guan, Y., Yang, J., Gu, J., Yang, S., & Xu, G. (2005) · Analytical Chemistry · doi:10.1021/ac0481001 · Cited by 270
Metabolomic Mapping of Atypical Antipsychotic Effects in Schizophrenia
Kaddurah-Daouk, R., McEvoy, J., Baillie, R. A., Lee, D., Yao, J. K., Doraiswamy, P. M., & Krishnan, K. R. R. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4002000 · Cited by 262
Metabonomics in pharmaceutical R & D
Lindon, J. C., Holmes, E., & Nicholson, J. K. (2007) · The FEBS Journal · doi:10.1111/j.1742-4658.2007.05673.x · Cited by 262
Role of norepinephrine in depression.
Delgado, P. L., & Moreno, F. A. (2000) · PubMed · Cited by 251
Styczynski, M. P., Moxley, J. F., Tong, L. V., Walther, J. L., Jensen, K. L., & Stephanopoulos, G. N. (2007) · Analytical Chemistry · doi:10.1021/ac0614846 · Cited by 245
De novo expansion of a (CAG)n repeat in sporadic Huntington's disease
Myers, R. H., MacDonald, M. E., Koroshetz, W. J., Duyao, M. P., Ambrose, C. M., Taylor, S. A. M., Barnes, G., Srinidhi, J., Lin, C. S., Whaley, W. L., et al. (1993) · Nature Genetics · doi:10.1038/ng1093-168 · Cited by 244
Increased cerebrospinal fluid glutamine levels in depressed patients
Levine, J., Panchalingam, K., Rapoport, A., Gershon, S., McClure, R. J., & Pettegrew, J. W. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00284-x · Cited by 240 · cited 1×
“Glutamatergic abnormalities in MDD patients including decreased CSF Glu and glycine (Frye et al, 2007) but increased levels of Gln have been reported (Levine et al, 2000).”
BackgroundExtending the breadth of metabolite profiling by gas chromatography coupled to mass spectrometry
Fiehn, O. (2008) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2008.01.007 · Cited by 240
Structure-based profiling of metabolites and isotopomers by NMR
Fan, T. W.-M., & Lane, A. N. (2008) · Progress in Nuclear Magnetic Resonance Spectroscopy · doi:10.1016/j.pnmrs.2007.03.002 · Cited by 237
Serotonin Transporter Gene Variants and Behavior: A Comprehensive Review
Serretti, A., Calati, R., Mandelli, L., & De Ronchi, D. (2006) · Current Drug Targets · doi:10.2174/138945006779025419 · Cited by 222
(1984) · American Journal of Psychiatry · doi:10.1176/ajp.141.12.1533 · Cited by 212
YANG, J., XU, G., ZHENG, Y., KONG, H., PANG, T., LV, S., & YANG, Q. (2004) · Journal of Chromatography B · doi:10.1016/j.jchromb.2004.09.032 · Cited by 210
The Art and Practice of Systems Biology in Medicine: Mapping Patterns of Relationships
van der Greef, J., Martin, S., Juhasz, P., Adourian, A., Plasterer, T., Verheij, E. R., & McBurney, R. N. (2007) · Journal of Proteome Research · doi:10.1021/pr0606530 · Cited by 201
Brindle, J. T., Nicholson, J. K., Schofield, P. M., Grainger, D. J., & Holmes, E. (2003) · The Analyst · doi:10.1039/b209155k · Cited by 191
Bhagwagar, Z., Wylezinska, M., Jezzard, P., Evans, J., Boorman, E., M. Matthews, P., & J. Cowen, P. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145707007924 · Cited by 186
Huntington disease patients and transgenic mice have similar pro-catabolic serum metabolite profiles
Underwood, B. R., Broadhurst, D., Dunn, W. B., Ellis, D. I., Michell, A. W., Vacher, C., Mosedale, D. E., Kell, D. B., Barker, R. A., Grainger, D. J., et al. (2006) · Brain · doi:10.1093/brain/awl027 · Cited by 183
Nutritional effects on blood pressure
Myers, V. H., & Champagne, C. M. (2007) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e328012d911 · Cited by 170
Coen, M., Ruepp, S. U., Lindon, J. C., Nicholson, J. K., Pognan, F., Lenz, E. M., & Wilson, I. D. (2004) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2003.12.019 · Cited by 164
Metabolic flux analysis with a comprehensive isotopomer model in Bacillus subtilis
Dauner, M., Bailey, J. E., & Sauer, U. (2001) · Biotechnology and Bioengineering · doi:10.1002/bit.1154 · Cited by 159
Recent Advances in the Neurobiology of Schizophrenia
Miyamoto, S. (2003) · Molecular Interventions · doi:10.1124/mi.3.1.27 · Cited by 156
Plasma GABA in affective illness
Petty, F., & Schlesser, M. A. (1981) · Journal of Affective Disorders · doi:10.1016/0165-0327(81)90003-3 · Cited by 154
Neurochemistry and Neuroendocrinology of Schizophrenia: A Selective Review
Lieberman, J. A., & Koreen, A. (1993) · Schizophrenia Bulletin · doi:10.1093/schbul/19.2.371 · Cited by 149
Low Cerebrospinal Fluid Glutamate and Glycine in Refractory Affective Disorder
Frye, M. A., Tsai, G. E., Huggins, T., Coyle, J. T., & Post, R. M. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.01.024 · Cited by 149
Pears, M. R., Cooper, J. D., Mitchison, H. M., Mortishire‐Smith, R. J., Pearce, D. A., & Griffin, J. L. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m507380200 · Cited by 147
Metabolomic analysis and signatures in motor neuron disease
Rozen, S., Cudkowicz, M., Bogdanov, M. B., Matson, W. R., Kristal, B. S., Beecher, C., Harrison, S. J., Vouros, P., Flarakos, J., Vigneau-Callahan, K. E., et al. (2005) · Metabolomics · doi:10.1007/s11306-005-4810-1 · Cited by 146
Self-citationPatterson, A. D., Li, H., Eichler, G. S., Krausz, K. W., Weinstein, J. N., Fornace, A. J., Gonzalez, F. J., & Idle, J. R. (2008) · Analytical Chemistry · doi:10.1021/ac701807v · Cited by 146
A preliminary metabolomic analysis of older adults with and without depression
Paige, L. A., Mitchell, M. W., Krishnan, K. R. R., Kaddurah‐Daouk, R., & Steffens, D. C. (2007) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1690 · Cited by 136
Self-citationA thematic review series: systems biology approaches to metabolic and cardiovascular disorders
Lusis, A. J. (2006) · Journal of Lipid Research · doi:10.1194/jlr.e600004-jlr200 · Cited by 136
Sanacora, G., & Sarıçiçek, A. (2007) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152707780363294 · Cited by 134
PINK1, Parkin, and DJ-1 mutations in Italian patients with early-onset parkinsonism
Klein, C., Djarmati, A., Hedrich, K., Schäfer, N., Scaglione, C. L. M., Marchese, R., Kock, N., Schüle, B., Hiller, A., Lohnau, T., et al. (2005) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201455 · Cited by 131
Serotonin and bipolar disorder
Mahmood, T., & Silverstone, T. (2001) · Journal of Affective Disorders · doi:10.1016/s0165-0327(00)00226-3 · Cited by 126
van Doorn, M. B. A., Vogels, J., Tas, A. C., van Hoogdalem, E. J., Burggraaf, J., Cohen, A. F., & van der Greef, J. (2006) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2006.02816.x · Cited by 125
Cerebrospinal fluid gamma-aminobutyric acid and homovanillic acid in depressive disorders.
Kasa, K., Otsuki, S., Yamamoto, M., Sato, M., Kuroda, H., & Ogawa, N. (1982) · PubMed · Cited by 117
Biogenic Amines and Affective Disorders
Schildkraut, J. J. (1974) · Annual Review of Medicine · doi:10.1146/annurev.me.25.020174.002001 · Cited by 116
Topical Review: The Neuronal Ceroid-Lipofuscinoses
Goebel, H. H. (1995) · Journal of Child Neurology · doi:10.1177/088307389501000602 · Cited by 115
Bloch, M. H., Landeros‐Weisenberger, A., Sen, S., Dombrowski, P., Kelmendi, B., Coric, V., Pittenger, C., & Leckman, J. F. (2008) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30699 · Cited by 108
Shin, H., & Markey, M. K. (2005) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2005.04.002 · Cited by 105
Selectivity and Types of Cell Death in the Neuronal Ceroid Lipofuscinoses (NCLs)
Mitchison, H. M., Lim, M. J., & Cooper, J. D. (2004) · Brain Pathology · doi:10.1111/j.1750-3639.2004.tb00502.x · Cited by 104
Pheno/genotypic correlations of neuronal ceroid lipofuscinoses
Wisniewski, K. E., Zhong, N. A., & Philippart, M. (2001) · Neurology · doi:10.1212/wnl.57.4.576 · Cited by 102
Further evidence for altered myelin biosynthesis and glutamatergic dysfunction in schizophrenia
Tkachev, D., Mimmack, M. L., Huffaker, S. J., Ryan, M., & Bahn, S. (2007) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145706007334 · Cited by 101
Peripheral Blood Markers of Oxidative Stress in Parkinson’s Disease
Younes, S., Frih-Ayed, M., Kerkeni, A., Bost, M., & Chazot, G. (2007) · European Neurology · doi:10.1159/000103641 · Cited by 97
Weiden, P. J., & Buckley, P. F. (2007) · PubMed · Cited by 92
Skosnik, P. D., & Yao, J. K. (2003) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2003.08.008 · Cited by 86
Jenkins, B. G., Andreassen, O. A., Dedeoglu, A., Leavitt, B. R., Hayden, M. R., Borchelt, D., Ross, C. A., Ferrante, R. J., & Beal, M. F. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03411.x · Cited by 83
Monitoring and Managing Weight Gain in the Mentally Ill
Ganguli, R., Vreeland, B., & Newcomer, J. W. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.0607e14 · Cited by 81
Genetics of Parkinson's disease
Morris, H. R. (2005) · Annals of Medicine · doi:10.1080/07853890510007269 · Cited by 80
Benefits and Risks of Antipsychotic Polypharmacy
Tranulis, C., Skalli, L., Lalonde, P., Nicole, L., & Stip, É. (2008) · Drug Safety · doi:10.2165/00002018-200831010-00002 · Cited by 78
Implications of lipid biology for the pathogenesis of schizophrenia
Berger, G. E., Wood, S. J., Pantelis, C., Velakoulis, D., Wellard, R. M., & McGorry, P. D. (2002) · Australian & New Zealand Journal of Psychiatry · doi:10.1046/j.1440-1614.2001.01021.x · Cited by 69
A GC-based metabonomics investigation of type 2 diabetes by organic acids metabolic profile
Yuan, K., Kong, H., Guan, Y., Yang, J., & Xu, G. (2006) · Journal of Chromatography B · doi:10.1016/j.jchromb.2006.11.035 · Cited by 69
Sobczak, S., Honig, A., van Duinen, M. A., & Riedel, W. J. (2002) · Bipolar Disorders · doi:10.1034/j.1399-5618.2002.01217.x · Cited by 68
Dunne, V. G., Bhattachayya, S., Besser, M., Rae, C. D., & Griffin, J. L. (2004) · NMR in Biomedicine · doi:10.1002/nbm.918 · Cited by 65
Presynaptic Receptors for Dopamine, Histamine, and Serotonin
Feuerstein, T. J. (2007) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-74805-2_10 · Cited by 63
Tsang, T. M., Huang, J. T.-J., Holmes, E. C., & Bahn, S. (2006) · Journal of Proteome Research · doi:10.1021/pr0503782 · Cited by 61
de Graaf, A. A., Mahle, M., Möllney, M., Wiechert, W., Stahmann, K. ‐., & Sahm, H. (2000) · Journal of Biotechnology · doi:10.1016/s0168-1656(99)00205-9 · Cited by 60
The Neuronal Ceroid‐Lipofuscinoses. Recent Advances
Goebel, H. H., & Sharp, J. D. (1998) · Brain Pathology · doi:10.1111/j.1750-3639.1998.tb00142.x · Cited by 58
Kristal, B. S., Shurubor, Y. I., Kaddurah-Daouk, R. F., & Matson, W. R. (2007) · Methods in molecular biology · doi:10.1007/978-1-59745-244-1_10 · Cited by 56
Self-citationNeurodegenerative disease: the neuronal ceroid lipofuscinoses (Batten disease)
Mitchison, H. M., & Mole, S. (2001) · Current Opinion in Neurology · doi:10.1097/00019052-200112000-00019 · Cited by 48
Metabolic Profiling of Patients with Schizophrenia
Kaddurah-Daouk, R. F. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030363 · Cited by 43
Self-citationCrocker, I. P., Kenny, L. C., Thornton, W. A., Szabó, C., & Baker, P. N. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706055 · Cited by 24
Biomarker discovery using high-dimensional lipid analysis
Wiest, M. M., & Watkins, S. M. (2007) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3280895d82 · Cited by 22
Lipomic profiling in drug discovery, development and clinical trial evaluation.
Watkins, S. M. (2004) · PubMed · Cited by 18
Fk, G., & Sack, R. L. (1974) · PubMed · Cited by 17
8.4 Metabolomics: Concepts and Potential Neuroscience Applications
Kristal, B. S., Kaddurah-Daouk, R. F., Beal, M. F., & Matson, W. R. (2007) · Springer eBooks · doi:10.1007/978-0-387-30411-3_33 · Cited by 8
Self-citationInsel, T. R. (2007) · Psychiatric Services · doi:10.1176/appi.ps.58.3.395 · Cited by 6
Insel, T. R. (2007) · Psychiatric Services · doi:10.1176/ps.2007.58.3.395 · Cited by 3
Cited by
Metabolomic analysis in food science: a review
Cevallos-Cevallos, J. M., Reyes-De-Corcuera, J. I., Etxeberria, E., Danyluk, M. D., & Rodrick, G. E. (2009) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2009.07.002 · Cited by 545
Metabolic network failures in Alzheimer's disease: A biochemical road map
Toledo, J. B., Arnold, M., Kastenmüller, G., Chang, R., Baillie, R. A., Han, X., Thambisetty, M., Tenenbaum, J. D., Suhre, K., Thompson, J. W., et al. (2017) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2017.01.020 · Cited by 468
Self-citationNOREVA: normalization and evaluation of MS-based metabolomics data
Li, B., Tang, J., Yang, Q., Li, S., Cui, X., Li, Y., Chen, Y., Xue, W., Li, X., & Zhu, F. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx449 · Cited by 352
The stem cell secretome and its role in brain repair
Drago, D., Cossetti, C., Iraci, N., Gaude, E., Musco, G., Bachi, A., & Pluchino, S. (2013) · Biochimie · doi:10.1016/j.biochi.2013.06.020 · Cited by 348
Genetic studies of quantitative MCI and AD phenotypes in ADNI: Progress, opportunities, and plans
Saykin, A. J., Shen, L., Yao, X., Kim, S., Nho, K., Risacher, S. L., Ramanan, V. K., Foroud, T. M., Faber, K. M., Sarwar, N., et al. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2015.05.009 · Cited by 306
Self-citation
Metadata
- Authors
- Kaddurah-Daouk, R., & Krishnan, K. R. R.
- Venue
- Neuropsychopharmacology
- Published
- 2008-10-08
- Volume
- 34
- Issue
- 1
- Pages
- 173-186
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W2163545549
- Cited by
- 293
- References
- 97
- FWCI
- 5.58
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.